Hainan Normal University
Haikou, Hainan, China
NCT Number: NCT07133542
The goal of this randomized controlled trial is to test whether a dual-dimensional 9-grid matrix intervention improves body composition and exercise adherence compared to standard aerobic exercise in overweight/obese college students. The main questions it aims to answer are:
Does the 9-grid model optimize fat distribution (measured by waist-hip ratio) and sustain body fat reduction better than traditional exercise?
Does dynamic risk stratification in the 9-grid system enhance long-term exercise adherence?
How does spatial migration of participants within the grid (quantified by centroid index G) reflect intervention efficacy?
Researchers will compare the 9-grid management group (receiving dynamic positioning + 5-tier personalized strategies) to the control group (receiving standardized aerobic exercise) to see if the 9-grid model:
Reduces waist-hip ratio more effectively
Delays intervention plateau in body fat loss
Increases exercise adherence at 8 weeks
Participants will:
Undergo body measurements (weight, body mass index (BMI), body fat percentage, waist/hip circumference) at baseline, 4 weeks, and 8 weeks
Complete the Exercise Adherence Rating Scale (EARS) at 4 and 8 weeks
If in 9-grid group:
* Be classified into 1 of 9 grid zones every 2 weeks based on waist circumference risk + body fat status * Receive zone-specific interventions (nutrition/exercise/behavioral guidance)
If in control group:
* Perform progressive aerobic exercise (40-90% heart rate reserve (HR) 3×/week * Use heart rate monitors for intensity tracking
Looking for future studies?
Notify Me18 year–36 year
All sexes
Interventional
Not applicable
Haikou, Hainan, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Precision weight management using a two-dimensional grid model. Participants undergo bi-weekly positioning on a waist risk-body fat matrix (9 grids), receiving tiered interventions (e.g., high-intensity exercise + dietary control for high-risk grids; maintenance plans for low-risk grids). Real-time progress feedback via visual spatial migration maps promotes adherence. Comparator group receives standardized aerobic prescription without dynamic adjustments.
Personalized progressive aerobic exercise program. Participants receive baseline-adjusted intensity prescriptions (40-90% heart rate reserve), with adherence monitored via wearable devices. NO dynamic adjustments, tiered strategies, or visual feedback are provided throughout the 8-week intervention.
Time frame: Baseline, Week 4, Week 8
Time frame: Baseline, Week 8
Time frame: Week 4, Week 8
Exercise adherence will be assessed using the standardized Exercise Adherence Rating Scale (EARS). This validated, self-reported questionnaire comprises 16 items. The first 6 items directly assess participants' behavioral adherence to the prescribed exercise regimen (e.g., session attendance, duration). The subsequent 10 items evaluate reasons for adherence or non-adherence, capturing key cognitive dimensions such as perceived barriers and motivation. All items are rated on a 5-point Likert scale ranging from "Completely Agree" (scored as 0) to "Completely Disagree" (scored as 4). Total scores are calculated such that higher scores indicate better exercise adherence.
Time frame: Baseline, Week 4, Week 8
Hainan Normal University
Other
The 9-Box Performance Management Framework: Impacts on Body Weight Regulation and Exercise Behaviors in Graduate Students
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07269795
Body Weight, Dyslipidemia
Elche, Alicante, Spain
View Trial DetailsNCT07276308
Behavior, Body Weight
Kota Bharu, Kelantan, Malaysia
View Trial DetailsNCT04616339
Overweight and/or Obesity
Brussels, Bruxelles-capitale, Région de, Belgium
View Trial DetailsNCT07400653
Body Weight, Diabetes Mellitus
Anaheim, California, United States
View Trial Details